Rifaximin-Alpha Increases Lactase Activity in Patients with Irritable Bowel Syndrome Without Constipation and Small Intestinal Bacterial Overgrowth
Digestive Diseases and Sciences · 2025
DOI: 10.1007/s10620-024-08767-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2025. Verfasst von María Fernanda García-Cedillo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Maestría y Doctorado en Ciencias Médicas, Odontológicas y de la Salud, Universidad Nacional Autónoma de México, Mexico City, Mexico. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Intestine, Small, Lactase, Rifamycins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Programa de Maestría y Doctorado en Ciencias Médicas, Odontológicas y de la Salud, Universidad Nacional Autónoma de México, Mexico City, Mexico.
- Gastrointestinal Motility Laboratory, Department of Gastroenterology, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico D.F., Mexico.
- Department of Gastroenterology, Centro Médico Nacional la Raza, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
- Internal Medicine Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- Gastrointestinal Motility Laboratory, Department of Gastroenterology, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico D.F., Mexico. enrique.cossa@incmnsz.mx.
Zitieren
APA
García-Cedillo, M. F., Villegas-García, F. U., Arenas-Martinez, J. S., Ornelas-Arroyo, V. J., Yamamoto-Furusho, J. K., Estrella-Sato, L. A., & Coss-Adame, E. (2025). Rifaximin-Alpha Increases Lactase Activity in Patients with Irritable Bowel Syndrome Without Constipation and Small Intestinal Bacterial Overgrowth. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08767-1
Vancouver
García-Cedillo MF, Villegas-García FU, Arenas-Martinez JS, Ornelas-Arroyo VJ, Yamamoto-Furusho JK, Estrella-Sato LA, et al. Rifaximin-Alpha Increases Lactase Activity in Patients with Irritable Bowel Syndrome Without Constipation and Small Intestinal Bacterial Overgrowth. Digestive Diseases and Sciences. 2025. doi:10.1007/s10620-024-08767-1
BibTeX
@article{GarcaCedillo2025,
author = {García-Cedillo, María Fernanda and Villegas-García, Federico Ulises and Arenas-Martinez, Josealberto Sebastiano and Ornelas-Arroyo, Victoria Jaqueline and Yamamoto-Furusho, Jesús Kazuo and Estrella-Sato, Luis Alberto and Coss-Adame, Enrique},
title = {Rifaximin-Alpha Increases Lactase Activity in Patients with Irritable Bowel Syndrome Without Constipation and Small Intestinal Bacterial Overgrowth},
journal = {Digestive Diseases and Sciences},
year = {2025},
doi = {10.1007/s10620-024-08767-1}
}
EUVIMED